desipramine has been researched along with Alloxan Diabetes in 9 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diabetic nephropathy is a common complication of diabetes, but there are currently few treatment options." | 1.48 | Alpha-mangostin attenuates diabetic nephropathy in association with suppression of acid sphingomyelianse and endoplasmic reticulum stress. ( Duan, W; Gao, L; Lei, M; Liao, Z; Liu, L; Liu, T; Nizigiyimana, P; Xu, B, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Levitsky, Y | 1 |
| Hammer, SS | 1 |
| Fisher, KP | 1 |
| Huang, C | 1 |
| Gentles, TL | 1 |
| Pegouske, DJ | 1 |
| Xi, C | 1 |
| Lydic, TA | 1 |
| Busik, JV | 1 |
| Proshlyakov, DA | 1 |
| Liu, T | 1 |
| Duan, W | 1 |
| Nizigiyimana, P | 1 |
| Gao, L | 1 |
| Liao, Z | 1 |
| Xu, B | 1 |
| Liu, L | 1 |
| Lei, M | 1 |
| Kamei, J | 1 |
| Miyata, S | 1 |
| Morita, K | 1 |
| Saitoh, A | 1 |
| Takeda, H | 1 |
| Ido, Y | 2 |
| Chang, K | 2 |
| LeJeune, W | 2 |
| Tilton, RG | 2 |
| Monafo, WW | 1 |
| Williamson, JR | 2 |
| Kiyono, Y | 1 |
| Iida, Y | 1 |
| Kawashima, H | 1 |
| Tamaki, N | 1 |
| Nishimura, H | 1 |
| Saji, H | 1 |
| Massol, J | 3 |
| Martin, P | 3 |
| Chatelain, F | 2 |
| Puech, AJ | 3 |
| Belon, JP | 1 |
| Soubrié, P | 2 |
9 other studies available for desipramine and Alloxan Diabetes
| Article | Year |
|---|---|
Mitochondrial Ceramide Effects on the Retinal Pigment Epithelium in Diabetes.
Topics: Animals; Blood-Retinal Barrier; Ceramides; Citrate (si)-Synthase; Desipramine; Diabetes Mellitus, Ex | 2020 |
Alpha-mangostin attenuates diabetic nephropathy in association with suppression of acid sphingomyelianse and endoplasmic reticulum stress.
Topics: Activating Transcription Factor 4; Albuminuria; Animals; Apoptosis; Blood Glucose; Caspase 12; Desip | 2018 |
Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Blood Glucose; Body Weight; Desipramine; | 2003 |
Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: implications for diabetic neuropathy.
Topics: Aldehyde Reductase; Animals; Desipramine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; En | 1997 |
Increased sciatic nerve blood flow in diabetic rats: assessment by "molecular" vs. particulate microspheres.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Blood Pressure; Desipramine; Diabetes Mellitus, Experime | 1997 |
Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
Topics: 3-Iodobenzylguanidine; Animals; Autoradiography; Chromatography, High Pressure Liquid; Coronary Circ | 2001 |
Tricyclic antidepressants, thyroid function, and their relationship with the behavioral responses in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Arousal; Avoidance Learning; Clomipramine; Conditioning, | 1990 |
Helpless behavior (escape deficits) in streptozotocin-diabetic rats: resistance to antidepressant drugs.
Topics: Animals; Antidepressive Agents; Brain; Clenbuterol; Clomipramine; Conditioning, Operant; Desipramine | 1989 |
Impaired response of experimental diabetic mice to tricyclics: a possible beta-adrenergic mechanism.
Topics: Animals; Clenbuterol; Clomipramine; Desipramine; Diabetes Mellitus, Experimental; Dose-Response Rela | 1988 |